Aqr Capital Management LLC Vertex Pharmaceuticals Inc Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 480,861 shares of VRTX stock, worth $219 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

480,861

Previous 536,114 10.31%

Holding current value

$219 Million

Previous $251 Million 11.0%

% of portfolio

0.31%

Previous 0.39%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $25.4 Million - $27.9 Million	-55,253 Reduced 10.31%	480,861 $224 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $51.3 Million - $63.4 Million	-130,577 Reduced 19.59%	536,114 $251 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $8.94 Million - $9.78 Million	21,923 Added 3.4%	666,691 $279 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $435,953 - $521,974	1,271 Added 0.2%	644,768 $262 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $10.5 Million - $11.3 Million	31,067 Added 5.07%	643,497 $224 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $12.9 Million - $14.4 Million	40,915 Added 7.16%	612,430 $216 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $4.55 Million - $5.2 Million	-16,079 Reduced 2.74%	571,515 $180 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $26.6 Million - $29.9 Million	93,063 Added 18.82%	587,594 $170 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $6.09 Million - $6.8 Million	-22,253 Reduced 4.31%	494,531 $143 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $3.96 Million - $4.93 Million	16,840 Added 3.37%	516,784 $144 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $21.8 Million - $25.7 Million	-98,539 Reduced 16.46%	499,944 $129 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $7.23 Million - $9.12 Million	-40,834 Reduced 6.39%	598,483 $131 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $12.2 Million - $13.7 Million	-67,436 Reduced 9.54%	639,317 $116 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $38.2 Million - $45.1 Million	-203,774 Reduced 22.38%	706,753 $139 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $72.5 Million - $84.5 Million	350,146 Added 62.48%	910,527 $195 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $17.4 Million - $23.2 Million	-83,887 Reduced 13.02%	560,381 $129 Million
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $8.3 Million - $9.84 Million	32,453 Added 5.3%	644,268 $175 Million
Q2 2020 Aug 17, 2020	BUY	$225.48 - $295.8 $3.82 Million - $5.01 Million	16,945 Added 2.85%	611,815 $176 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $36.9 Million - $45.7 Million	184,560 Added 44.98%	594,870 $138 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $23 Million - $30.9 Million	138,186 Added 50.78%	410,310 $89.6 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $3.68 Million - $4.15 Million	22,158 Added 8.86%	272,124 $45.8 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $32 Million - $37 Million	-194,184 Reduced 43.72%	249,966 $45 Million
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $51.6 Million - $61.3 Million	-314,883 Reduced 41.48%	444,150 $81 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $79.3 Million - $100 Million	-522,311 Reduced 40.76%	759,033 $126 Million
Q3 2018 Nov 15, 2018	BUY	$167.73 - $192.74 $75.4 Million - $86.6 Million	449,549 Added 54.05%	1,281,344 $247 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $63 Million - $73.5 Million	-432,617 Reduced 34.21%	831,795 $141 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $38.4 Million - $44.9 Million	-253,423 Reduced 16.7%	1,264,412 $206 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $51.2 Million - $58 Million	-372,855 Reduced 19.72%	1,517,835 $227 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $280 Million - $307 Million	1,890,690	1,890,690 $287 Million

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

223M

Call Options Held

1.64M

Put Options Held

1.37M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $117B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Vertex Pharmaceuticals Inc Transaction History